Immatics (IMTX) Interest Income - Total (2019 - 2025)
Immatics (IMTX) posted Interest Income - Total of -$4.1 million for Q4 2025, up 9.6% sequentially from -$4.6 million in Q3 2025, and up 43.26% YoY from -$2.9 million in Q4 2024.
Immatics (IMTX) Interest Income - Total (2019 - 2025) Analysis & Trends
Immatics has reported Interest Income - Total for 7 years, with the latest figure at -$4.1 million in Q4 2025.
- Quarterly Interest Income - Total rose 43.26% year-over-year to -$4.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$19.3 million (up 28.76% YoY) and the FY2025 annual result came in at -$19.4 million, up 28.27% from the prior year.
- Interest Income - Total grew to -$4.1 million in Q4 2025 per IMTX's latest filing, from -$4.6 million in the prior quarter.
- Over five years, Interest Income - Total peaked at $9.7 million in Q4 2023 and troughed at -$7.3 million in Q4 2024.
- A 5-year average of -$2.5 million and a median of -$2.7 million in 2023 frame the typical range for Interest Income - Total.
- The widest YoY moves for Interest Income - Total: up 606.38% in 2023, down 35826.69% in 2023.
- Over 5 years, Interest Income - Total stood at -$35463.1 in 2021, then plunged by 5279.85% to -$1.9 million in 2022, then jumped by 606.38% to $9.7 million in 2023, then tumbled by 175.39% to -$7.3 million in 2024, then soared by 43.26% to -$4.1 million in 2025.
- According to Business Quant data, Interest Income - Total over the past three periods registered -$4.1 million, -$4.6 million, and -$4.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Total (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Immatics | 1.27 Bn | 719.31 Mn | - | -4.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.13 Mn |
| Dec 31, 2025 | -4.13 Mn |
| Sep 30, 2025 | -4.57 Mn |
| Sep 30, 2025 | -4.57 Mn |
| Jun 30, 2025 | -4.82 Mn |
| Jun 30, 2025 | -4.82 Mn |
| Mar 31, 2025 | -5.75 Mn |
| Mar 31, 2025 | -5.75 Mn |
| Dec 31, 2024 | -7.28 Mn |
| Dec 31, 2024 | -7.28 Mn |
| Sep 30, 2024 | -6.07 Mn |
| Sep 30, 2024 | -6.07 Mn |
| Jun 30, 2024 | -6.86 Mn |
| Jun 30, 2024 | -6.86 Mn |
| Mar 31, 2024 | -6.84 Mn |
| Mar 31, 2024 | -6.84 Mn |
| Dec 31, 2023 | 9.66 Mn |
| Dec 31, 2023 | 9.66 Mn |
| Sep 30, 2023 | -4.35 Mn |
| Sep 30, 2023 | -4.35 Mn |